Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
TMTransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX)

NASDAQ Global Market · Currency in USD
$70.74 ▼ -1.32 (-1.83%)
At close: Oct 23, 4:00 PM ET. Market closed.
$70.50 ▼ -0.24 (-0.34%)
After hours: Oct 23, 7:49 PM ET

Summary

Previous Close
$72.06
Open
$71.42
Day's Range
$69.76 – $72.68
52 Week Range
$60.11 – $156.00
Volume
789,576
Avg. Volume
882,971
Market Cap
$2.45B
Beta (5Y Monthly)
1.93
PE Ratio (TTM)
16.00
EPS (TTM)
$4.39
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$99.63

Profile: TransMedics Group, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
898
CEO
Waleed H. Hassanein

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate $0.30 · Revenue est. $178.06M
DateEst.Actual
Aug 4, 2026$0.50$0.44Miss
May 5, 2026$0.62$0.30Miss
Feb 24, 2026$0.41$0.57Beat
Oct 29, 2025$0.37$0.66Beat
Jul 30, 2025$0.48$0.92Beat
May 8, 2025$0.29$0.70Beat

Analyst view

Consensus price target
$99.63 ▲ +40.8%
Range $65.00 – $122.00
Rating: Buy
Buy 69% · Hold 31% · Sell 0%

Get free alerts on TMDX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.